News & Analysis as of August 16, 2025

Teva Pharmaceuticals

+ Follow

A repository for the most well-read content on JD Supra at any given time, along with occasional roundups of popular content by specific topic. Also stop by for monthly recaps of hot articles for the previous... more +

FDA Accepts U.S. Biologics License Application for AVT06, Alvotech and Teva’s Proposed Aflibercept Biosimilar

Goodwin on 2/24/2025

On February 18, 2025, Alvotech and Teva Pharmaceuticals (“Teva”) announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for AVT06, a proposed biosimilar to...more

Alert: GSK v. Teva – Induced Infringement Liability Despite Skinny Label

Cooley LLP on 10/7/2020

In GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., the Federal Circuit reinstated a jury's verdict that Teva infringed GSK's patented method of using its Coreg® drug product, even though Teva's product was initially...more

Teva and Alvotech Announce Partnership in the U.S. Biosimilar Market

Rothwell, Figg, Ernst & Manbeck, P.C. on 8/24/2020

Pharmaceutical companies Teva Pharmaceutical Industries Ltd. and Alvotech announced on Wednesday, August 5, 2020, that they will be entering into an exclusive partnership for the commercialization of biosimilar products in...more

Alvotech and Teva Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market

Goodwin on 8/7/2020

Today Alvotech and Teva announced that they have entered into an exclusive strategic partnership for the commercialization of five biosimilar candidates in the U.S. Under the partnership agreement, Alvotech will be...more

Year in Review: The Top-Five U.S. Biosimilar Market Developments of 2019

Goodwin on 1/3/2020

As we start the new year, we look back at the top U.S. biosimilar market developments of 2019. Here are some of our highlights, in no particular order...more

Year In Review: Top Five Biosimilars Deals of 2016

Goodwin on 12/30/2016

After another milestone year, here are our picks for the top-five biggest deals in the world of biosimilars in 2016: As we reported in January 2016, Mylan N.V. and Momenta Pharmaceuticals, Inc. entered into an...more

6 Results

View per page

Page: of 1